U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    PTTG1 PTTG1 regulator of sister chromatid separation, securin [ Homo sapiens (human) ]

    Gene ID: 9232, updated on 27-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Identification and validation of tryptophan-related gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma reveals a critical role for PTTG1.

    Identification and validation of tryptophan-related gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma reveals a critical role for PTTG1.
    Wang Z, Zhang J, Zuo C, Chen H, Wang L, Xie Y, Ma H, Min S, Wang X, Lian C., Free PMC Article

    08/21/2024
    Multi-Omics Analysis of the Oncogenic Value of Pituitary Tumor-Transforming Gene 1 (PTTG1) in Human Cancers.

    Multi-Omics Analysis of the Oncogenic Value of Pituitary Tumor-Transforming Gene 1 (PTTG1) in Human Cancers.
    Wang L, Liu X.

    03/4/2024
    Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-kappaB signaling.

    Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-κB signaling.
    Hu X, Yang F, Mei H.

    01/16/2024
    SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma.

    SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma.
    Teveroni E, Di Nicuolo F, Vergani E, Oliva A, Vodola EP, Bianchetti G, Maulucci G, De Spirito M, Cenci T, Pierconti F, Gulino G, Iavarone F, Urbani A, Milardi D, Pontecorvi A, Mancini F., Free PMC Article

    12/20/2023
    Phosphorylated PTTG1 switches its subcellular distribution and promotes beta-catenin stabilization and subsequent transcription activity.

    Phosphorylated PTTG1 switches its subcellular distribution and promotes β-catenin stabilization and subsequent transcription activity.
    Zhang X, Wu N, Huang H, Li S, Liu S, Zhang R, Huang Y, Lyu H, Xiao S, Ali DW, Michalak M, Chen XZ, Zhou C, Tang J.

    08/9/2023
    miR374c5p regulates PTTG1 and inhibits cell growth and metastasis in hepatocellular carcinoma by regulating epithelialmesenchymal transition.

    miR‑374c‑5p regulates PTTG1 and inhibits cell growth and metastasis in hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.
    Yang G, Xiog Y, Wang G, Li W, Tang T, Sun J, Li J., Free PMC Article

    07/16/2022
    Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer.

    Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer.
    Li JD, Farah AA, Huang ZG, Zhai GQ, Wang RG, Liu JL, Wang QJ, Zhang GL, Lei ZL, Dang YW, Li SH., Free PMC Article

    07/9/2022
    SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression.

    SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression.
    Huang J, Zhang F, Hu G, Pan Y, Sun W, Jiang L, Wang P, Qiu J, Ding X.

    06/25/2022
    The pituitary tumour-transforming gene 1/delta-like homologue 1 pathway plays a key role in liver fibrogenesis.

    The pituitary tumour-transforming gene 1/delta-like homologue 1 pathway plays a key role in liver fibrogenesis.
    Perramón M, Carvajal S, Reichenbach V, Fernández-Varo G, Boix L, Macias-Muñoz L, Melgar-Lesmes P, Bruix J, Melmed S, Lamas S, Jiménez W., Free PMC Article

    03/12/2022
    miR-362-3p suppresses sinonasal squamous cell carcinoma progression via directly targeting pituitary tumor-transforming gene 1.

    miR-362-3p suppresses sinonasal squamous cell carcinoma progression via directly targeting pituitary tumor-transforming gene 1.
    Meng Z, Zhu S, Liu N, Tian J.

    02/19/2022
    Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.

    Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
    Lei X, Zhang M, Guan B, Chen Q, Dong Z, Wang C., Free PMC Article

    02/5/2022
    Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.

    Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
    Huang Z, Li B, Guo Y, Wu L, Kou F, Yang L., Free PMC Article

    12/25/2021
    [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].

    [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
    Zheng J, Zhang YW, Pan ZF.

    11/22/2021
    KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p.

    KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p.
    Zhou M, Chen J, Zhang H, Liu H, Yao H, Wang X, Zhang W, Zhao Y, Yang N., Free PMC Article

    11/13/2021
    Structural basis of human separase regulation by securin and CDK1-cyclin B1.

    Structural basis of human separase regulation by securin and CDK1-cyclin B1.
    Yu J, Raia P, Ghent CM, Raisch T, Sadian Y, Cavadini S, Sabale PM, Barford D, Raunser S, Morgan DO, Boland A., Free PMC Article

    09/4/2021
    Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.

    Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
    Wu CC, Ekanem TI, Phan NN, Loan DTT, Hou SY, Lee KH, Wang CY., Free PMC Article

    08/7/2021
    CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.

    CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.
    Dai L, Song ZX, Wei DP, Zhang JD, Liang JQ, Wang BB, Ma WT, Li LY, Dang YL, Zhao L, Zhang LM, Zhao YM.

    06/26/2021
    Suppression of PTTG1 inhibits cell angiogenesis, migration and invasion in glioma cells.

    Suppression of PTTG1 inhibits cell angiogenesis, migration and invasion in glioma cells.
    Cui L, Ren T, Zhao H, Chen S, Zheng M, Gao X, Feng D, Yang L, Jin X, Zhuo R.

    06/26/2021
    Upregulation of PTTG1 is associated with poor prognosis in prostate cancer.

    Upregulation of PTTG1 is associated with poor prognosis in prostate cancer.
    Fraune C, Yehorov S, Luebke AM, Steurer S, Hube-Magg C, Büscheck F, Höflmayer D, Tsourlakis MC, Clauditz TS, Simon R, Sauter G, Weidemann S, Dum D, Kind S, Minner S, Schlomm T, Huland H, Heinzer H, Graefen M, Burandt E.

    05/1/2021
    The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1.

    The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1.
    Huang S, Liao Q, Li W, Deng G, Jia M, Fang Q, Ji H, Meng M.

    04/17/2021
    Alteration of Pituitary Tumor Transforming Gene 1 by MicroRNA-186 and 655 Regulates Invasion Ability of Human Oral Squamous Cell Carcinoma.

    Alteration of Pituitary Tumor Transforming Gene 1 by MicroRNA-186 and 655 Regulates Invasion Ability of Human Oral Squamous Cell Carcinoma.
    Lee SS, Choi JH, Lim SM, Kim GJ, Lee SK, Jeon YK., Free PMC Article

    04/13/2021
    [MiR-300 inhibits invasion and metastasis of osteosarcoma cell MG63 by negatively regulating PTTG1].

    [MiR-300 inhibits invasion and metastasis of osteosarcoma cell MG63 by negatively regulating PTTG1].
    Liang D, Wu X, Bai J, Zhang L, Yin C, Zhong W., Free PMC Article

    02/27/2021
    aarF domain containing kinase 5 gene promotes invasion and migration of lung cancer cells through ADCK5-SOX9-PTTG1 pathway.

    aarF domain containing kinase 5 gene promotes invasion and migration of lung cancer cells through ADCK5-SOX9-PTTG1 pathway.
    Qiu M, Li G, Wang P, Li X, Lai F, Luo R, Liu B, Lin J.

    01/2/2021
    Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.

    Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.
    Buus R, Sestak I, Barron S, Loughman T, Fender B, Ruiz CL, Dynoodt P, Wang CA, O'Leary D, Gallagher WM, Dowsett M, Cuzick J.

    12/19/2020
    [Expression of pituitary tumor-transforming gene-1 and its pathogenic role in systemic sclerosis].

    [Expression of pituitary tumor-transforming gene-1 and its pathogenic role in systemic sclerosis].
    Yang A, Huang Y, Zhang Y, Yang K, Wang J, Liu Q., Free PMC Article

    12/5/2020
    firstprevious page of 9 nextlast